New arthritis injection trial halted before starting
Disease control
Terminated
This early-stage study aimed to test the safety and find the right dose of an experimental drug called F8IL10, given as injections directly into inflamed joints of people with rheumatoid arthritis. The trial was designed for patients whose arthritis flared up despite being on sta…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC